early breast cancer
The reoperation lottery
The odds that a woman will be told she needs a reoperation after conservative breast surgery vary between treatment centres, prompting calls for international guidelines and greater oversight of surgeons. For many women with [more]
Optimising dose-dense regimens for early breast cancer
Clifford Hudis takes a look at how dose-dense regimens, intended to increase efficacy by decreasing the time between doses, work and effect toxicity in early breast cancer, especially where targeted agents are added. Dose-dense regimens [more]